Prognostic Significance of Plasmablastic Plasma Cells in the Era of Novel Agents in Multiple Myeloma

被引：0
|
作者：
Machet, Antoine
Guidez, Stephanie
Fouquet, Guillemette
Systchenko, Thomas
Desmier, Deborah
Moya, Niels
Gruchet, Cecile
Levy, Anthony
Sabirou, Florence
Bobin, Arthur
Richez, Valentine
Dieval, Celine
Motard, Carine
Borde, Florence
Durand, Geraldine
Azais, Isabelle
Javaugue, Vincent
Tomowiak, Cecile
Bouyer, Sabrina
Ghoual, Ouda
Dindinaud, Elodie
Bridoux, Frank
Sonneveld, Pieter
Loiseau, Herve Avet
Leleu, Xavier
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1877
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Prognostic significance of apoptotic index in multiple myeloma patients treated by conventional therapy and novel agents, thalidomide and bortezomib
    Minarik, Jiri
    Scudla, Vlastimil
    Ordeltova, Marta
    Bacovsky, Jaroslav
    Pika, Tomas
    Langova, Katerina
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 83 (06) : 528 - 534
  • [42] SIGNIFICANCE OF CIRCULATING PLASMA-CELLS IN MULTIPLE-MYELOMA
    ZANDECKI, M
    FACON, T
    PREUDHOMME, C
    CANIS, F
    IZYDORCZYK, V
    LOVI, V
    HAMMAD, M
    BAUTERS, F
    COSSON, A
    LEUKEMIA & LYMPHOMA, 1994, 14 (5-6) : 491 - 496
  • [43] PROGNOSTIC SIGNIFICANCE OF T(11;14) EXPRESSION BY FISH IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA IN THE ERA OF NOVEL THERAPIES
    Velez, M. Gonzalez
    Parrondo, R.
    Andrews, T.
    Duma, N.
    Richter, J.
    Vesole, D. H.
    Siegel, D. S.
    Biran, N.
    HAEMATOLOGICA, 2017, 102 : 523 - 523
  • [44] 'Old' prognostic factors for multiple myeloma (MM); are they still valuable in the era of 'new' agents
    Kyrtsonis, Marie-Christine
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S105 - S105
  • [45] BONE MARROW RETICULIN FIBROSIS AS A PROGNOSTIC MARKER IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED IN THE ERA OF NOVEL AGENTS
    Suriu, C.
    Livne, M.
    Sonkin, V.
    Akria, L.
    Barhoum, M.
    Braester, A.
    HAEMATOLOGICA, 2016, 101 : 793 - 793
  • [46] Clinical Significance of Circulating Clonal Plasma Cells Detected by a Novel Microfluidic Chip in Multiple Myeloma
    Ouyang, Dongfang
    Zhang, Hanqing
    Tang, Bin
    Park, Jaewon
    Hu, Lina
    Hirst, Jenny
    You, Lidan
    Li, Yonghua
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2022, 18 (06) : 1630 - 1639
  • [47] Novel Agents in Multiple Myeloma
    Szalat, Raphael
    Munshi, Nikhil C.
    CANCER JOURNAL, 2019, 25 (01): : 45 - 53
  • [48] PROGNOSTIC-SIGNIFICANCE OF PLASMA-CELL MORPHOLOGY IN MULTIPLE-MYELOMA
    PAULE, B
    QUILLARD, J
    BISSON, M
    KAHN, MF
    MASSIAS, P
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1988, 30 (04): : 209 - 212
  • [49] PROGNOSTIC-SIGNIFICANCE OF PLASMA-CELL MORPHOLOGY IN MULTIPLE-MYELOMA
    CARTER, A
    HOCHERMAN, I
    LINN, S
    COHEN, Y
    TATARSKY, I
    CANCER, 1987, 60 (05) : 1060 - 1065
  • [50] A Risk Stratification Model Using Quantification of Circulating Plasma Cells in Multiple Myeloma Prior to Autologous Stem Cell Transplantation in the Era of Novel Agents
    Chakraborty, Rajshekhar
    Muchtar, Eli
    Kumar, Shaji
    Jevremovic, Dragan
    Buadi, Francis K.
    Dingli, David
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Hogan, William J.
    Kapoor, Prashant
    Lacy, Martha Q.
    Leung, Nelson
    Gertz, Morie A.
    BLOOD, 2016, 128 (22)
12345